Prof. Dr. med. Christian Doehn

Urology

Professor Doehn founded the Urologikum Lübeck in 2011. Before that he worked for 8 years as senior physician at University Hospital of Lübeck. He have done many assignments in England.

Professor Doehn has authored nearly 200 publications and more than 30 articles in textbooks. He has given more than 500 lectures and was accredited 18 prizes (9 in Germany and 9 international) for his academic works.

2011 Founder of department of urology at University of Lübeck

2009 – date Coordinator of the German S3 guideline renal cell carcinoma

2003 – 2011 Consultant physician and Deputy Director, Department of Urology, University of Lübeck

1999 – 2003 Senior Physician, Department of Urology, University of Lübeck

1999 Recognition as urology specialist

1995 – 1999 Assistant doctor, Department of Urology, University of Lübeck

1995 Assistant doctor, Renal Transplant Unit, Royal Victoria Infirmary, Newcastle upon Tyne, England

1994 – 1995 Assistant doctor, Department of Urology, University of Lübeck

1985 – 1992 Study of Medicine, University of Hamburg – University of Birmingham, Birmingham, England – St. Bartholomew’s Medical School, London, England

2008 – now, Member and Speaker of RCC, consortium of Urologic Oncologist (AUO) of the German Society of Urology (DGU)

2008 – 2011 Speaker of the Interdisciplinary consortium renal cell carcinoma (IAG-N) of the German Cancer Society (DKG), together with Prof. Dr. L. Bergmann, Internal Medicine II, University of Frankfurt

Bergmann L, Kube U, Doehn C, et al. Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study. BMC Cancer. 2015 Apr 18;15:303.

Miller K, Bergmann L, Doehn C, Grünwald V, Gschwend J, Kuczyk M. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. Aktuelle Urol. 2015 Mar;46(2):151-7.

Steiner T, Doehn C, Roigas J. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma. J Cancer Res Clin Oncol. 2010 Jun;136(6):905-10.

Jocham D, Doehn C. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet. 2004 Feb 21;363(9409):594-9.

Doehn C, Jocham D. Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer? Nat Clin Pract Urol. 2008 Dec;5(12):644-5.

Register here for your second opinion

Straight to the second opinion
Do you have any questions or requests?
Simply call us on +49 30 555 7053 – 0 or use the contact form to send us a message.